Amgen to Present at the 31st Annual Global Healthcare Conference

Posted: January 4th, 2013  |  Company/topic: Amgen
Website: BioSpace.com Featured News
THOUSAND OAKS, Calif., Jan. 3, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 31st Annual J.P. Morgan Global Healthcare Conference at 9:00 a.m. Pacific Standard Time on Tuesday, Jan. 8,…
Tags: , , , , ,

Amgen Announces Appointment of to Board of Directors

Posted: December 14th, 2012  |  Company/topic: Amgen
Website: BioSpace.com Featured News
THOUSAND OAKS, Calif., Dec. 13, 2012 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced the appointment of Robert A. Eckert, former chief executive officer at Mattel, Inc., to its Board of Directors…
Tags: , , , , ,

Amgen Highlights Data to be Presented at American Society of Hematology Annual Meeting

Posted: December 6th, 2012  |  Company/topic: Amgen
Website: BioSpace.com Featured News
THOUSAND OAKS, Calif., Dec. 5, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will present data from several studies at the 54th Annual Meeting of the American Society of Hematology…
Tags: , , , ,

Amgen’s Second Quarter 2012 Revenues Increased 13 Percent to $4.5 Billion And Adjusted Earnings Per Share (EPS) Increased 34 Percent to $1.83

Posted: July 30th, 2012  |  Company/topic: Amgen
Website: BioSpace.com Featured News
THOUSAND OAKS, Calif., July 26, 2012 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2012. Key results for the quarter include:Total revenues increased…
Tags: , , , , ,